| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,705 |
21,252 |
$2.09M |
| 99199 |
Unlisted special service, procedure or report |
236,570 |
119,252 |
$1.77M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,792 |
12,440 |
$877K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,648 |
6,777 |
$687K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,176 |
6,984 |
$676K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,024 |
6,952 |
$669K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13,435 |
11,323 |
$453K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,277 |
4,282 |
$448K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
21,741 |
18,415 |
$403K |
| D0145 |
Oral evaluation for a patient under three years of age |
4,559 |
3,956 |
$149K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,300 |
2,522 |
$148K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
16,754 |
14,048 |
$148K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,046 |
4,823 |
$144K |
| 99408 |
|
5,280 |
4,240 |
$108K |
| 96127 |
|
17,779 |
14,270 |
$84K |
| 99460 |
|
1,036 |
892 |
$72K |
| D1206 |
Topical application of fluoride varnish |
4,548 |
3,937 |
$65K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,110 |
952 |
$62K |
| 90474 |
|
3,148 |
2,599 |
$60K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,083 |
3,531 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
894 |
745 |
$34K |
| 99050 |
|
1,612 |
1,443 |
$32K |
| 90651 |
|
2,970 |
2,492 |
$30K |
| 83718 |
|
3,488 |
2,930 |
$30K |
| 87807 |
|
1,559 |
1,291 |
$20K |
| 99215 |
Prolong outpt/office vis |
177 |
145 |
$19K |
| 99381 |
|
231 |
178 |
$19K |
| 99401 |
|
840 |
452 |
$16K |
| 82465 |
|
3,486 |
2,929 |
$16K |
| 96161 |
|
4,737 |
3,911 |
$15K |
| 0071A |
|
310 |
220 |
$15K |
| 0001A |
|
288 |
215 |
$14K |
| 0002A |
|
308 |
198 |
$13K |
| 85018 |
|
6,940 |
5,754 |
$11K |
| 0072A |
|
206 |
143 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
326 |
298 |
$11K |
| 90734 |
|
629 |
565 |
$8K |
| 99462 |
|
250 |
175 |
$8K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
49 |
42 |
$7K |
| 92552 |
|
17,737 |
14,878 |
$7K |
| 99383 |
|
66 |
59 |
$6K |
| 90619 |
|
1,676 |
1,353 |
$3K |
| 99384 |
|
34 |
28 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
23 |
15 |
$3K |
| 90686 |
|
5,145 |
4,477 |
$3K |
| 99173 |
|
16,361 |
13,892 |
$2K |
| 90621 |
|
654 |
548 |
$2K |
| 90715 |
|
1,036 |
858 |
$2K |
| 94664 |
|
143 |
114 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
152 |
141 |
$1K |
| 81003 |
|
289 |
236 |
$647.22 |
| 90633 |
|
3,340 |
2,845 |
$511.29 |
| 94760 |
|
2,245 |
1,891 |
$449.51 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
22 |
20 |
$300.73 |
| 90677 |
|
754 |
705 |
$286.21 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
13 |
$215.88 |
| 90716 |
|
578 |
488 |
$145.98 |
| 90744 |
|
2,865 |
2,357 |
$124.26 |
| 91307 |
|
576 |
395 |
$34.90 |
| 36416 |
|
2,312 |
1,874 |
$9.67 |
| 94761 |
|
95 |
83 |
$7.90 |
| 90680 |
|
3,354 |
2,745 |
$0.00 |
| 90698 |
|
5,964 |
4,934 |
$0.00 |
| 90656 |
|
518 |
478 |
$0.00 |
| 90696 |
|
736 |
595 |
$0.00 |
| 99000 |
|
835 |
762 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$0.00 |
| 90697 |
|
94 |
89 |
$0.00 |
| 90688 |
|
33 |
28 |
$0.00 |
| 90670 |
|
5,402 |
4,460 |
$0.00 |
| 91300 |
|
783 |
491 |
$0.00 |
| 90710 |
|
761 |
610 |
$0.00 |
| J7645 |
Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
97 |
91 |
$0.00 |
| 90707 |
|
517 |
445 |
$0.00 |
| 90685 |
|
180 |
154 |
$0.00 |
| 90700 |
|
36 |
36 |
$0.00 |